Bioscience

InNexus working with Cancer Institute

May 27, 2010

By Flinn Foundation

[Source: Phoenix Business Journal] – InNexus Biotechnology Inc. is working with the National Cancer Institute on research related to new generation of antibodies based on the Canadian company’s “dynamic cross linking technology.”

For more information: InNexus working with Cancer Institute